• Howard G Birnbaum, Alan G White, Matt Schiller, Tracy Waldman, Jody M Cleveland, and Carl L Roland.
• Analysis Group, Inc., Boston, MA, USA. hbirnbaum@analysisgroup.com
• Pain Med. 2011 Apr 1; 12 (4): 657-67.

ObjectivesThe objective of this study was to estimate the societal costs of prescription opioid abuse, dependence, and misuse in the United States.MethodsCosts were grouped into three categories: health care, workplace, and criminal justice. Costs were estimated by 1) quantity method, which multiplies the number of opioid abuse patients by cost per opioid abuse patient; and 2) apportionment method, which begins with overall costs of drug abuse per component and apportions the share associated with prescription opioid abuse based on relative prevalence of prescription opioid to overall drug abuse. Excess health care costs per patient were based on claims data analysis of privately insured and Medicaid beneficiaries. Other data/information were derived from publicly available survey and other secondary sources.ResultsTotal US societal costs of prescription opioid abuse were estimated at $55.7 billion in 2007 (USD in 2009). Workplace costs accounted for $25.6 billion (46%), health care costs accounted for $25.0 billion (45%), and criminal justice costs accounted for $5.1 billion (9%). Workplace costs were driven by lost earnings from premature death ($11.2 billion) and reduced compensation/lost employment ($7.9 billion). Health care costs consisted primarily of excess medical and prescription costs ($23.7 billion). Criminal justice costs were largely comprised of correctional facility ($2.3 billion) and police costs ($1.5 billion).Conclusions  The costs of prescription opioid abuse represent a substantial and growing economic burden for the society. The increasing prevalence of abuse suggests an even greater societal burden in the future.Wiley Periodicals, Inc.

28 keywords...

hide…